Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...
an increase of approximately $5 million from December 31, 2023. Revenue Guidance (2025): $610 million to $630 million, representing 0% to 3% growth over 2024. 10x Genomics Inc (NASDAQ:TXG ...
Despite a challenging macro environment, 10x Genomics Inc (TXG) focuses on product innovation and biopharma expansion to ...
10.5 (Tree Star Inc.). Lysates from lymphoblastoid cells were ... and 8700 cells for each sample were loaded individually onto the Chromium Controller (10x Genomics). Analysis of single-cell RNA-seq ...
Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...
Image Source : FILE PHOTO Former Prime Ministers Jawaharlal Nehru and Manmohan Singh. Budget 2025: Finance Minister Nirmala Sitharaman is all set to present the Union Budget on February 1 ...
Hosted on MSN14d
5 Prime Video shows with 100% on Rotten TomatoesThe selection of TV series on Prime Video, including originals, library titles and international acquisitions, can be a bit dizzying. If you’re looking for a new show to watch and aren’t just ...
Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...
Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter, reporting revenues of $151.7 million, down 1.3% year on year. It was a softer quarter for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results